Combined PET/MRI: one step further in multimodality imaging

Riesz, 1995, The life of Wilhelm Conrad Roentgen, AJR Am. J. Roentgenol., 165, 1533, 10.2214/ajr.165.6.7484601 Cannon, 1902, The Movements of the Intestines studied by Means of the Rontgen Rays, J. Med. Res., 7, 72 Tselos, 1995, New Jersey's Thomas Edison and the fluoroscope, N. J. Med., 92, 731 Becquerel, 1948, Discovery of radioactivity, Nature, 161, 609, 10.1038/161609b0 Mould, 1998, The discovery of radium in 1898 by Maria Sklodowska-Curie (1867–1934) and Pierre Curie (1859–1906) with commentary on their life and times, Br. J. Radiol., 71, 1229, 10.1259/bjr.71.852.10318996 Leitha, 2009, Nuclear medicine: proof of principle for targeted drugs in diagnosis and therapy, Curr. Pharm. Des., 15, 173, 10.2174/138161209787002898 Donald, 1969, On launching a new diagnostic science, Am. J. Obstet. Gynecol., 103, 609, 10.1016/0002-9378(69)90559-6 Anger, 1952, Use of a gamma-ray pinhole camera for in vivo studies, Nature, 170, 200, 10.1038/170200b0 Kuhl, 1964, Cylindrical and Section Radioisotope Scanning of the Liver and Brain, Radiology, 83, 926, 10.1148/83.5.926 Levine, 1972, A class of biomathematical models for radiology imaging, Comput. Biol. Med., 2, 257, 10.1016/0010-4825(72)90027-3 Hounsfield, 1973, Computerized transverse axial scanning (tomography). 1. Description of system, Br. J. Radiol., 46, 1016, 10.1259/0007-1285-46-552-1016 Phelps, 1975, Application of annihilation coincidence detection to transaxial reconstruction tomography, J. Nucl. Med., 16, 210 Ter-Pogossian, 1975, A positron-emission transaxial tomograph for nuclear imaging (PETT), Radiology, 114, 89, 10.1148/114.1.89 Lauterbur, 1980, Progress in n.m.r. zeugmatography imaging, Philos Trans. R. Soc. Lond. B. Biol. Sci., 289, 483, 10.1098/rstb.1980.0066 Mansfield, 1976, Line scan proton spin imaging in biological structures by NMR, Phys. Med. Biol., 21, 847, 10.1088/0031-9155/21/5/013 Davies, 2004, Molecular and metabolic imaging of atherosclerosis, J. Nucl. Med., 45, 1898 Kiessling, 2009, Functional and molecular ultrasound imaging: concepts and contrast agents, Curr. Med. Chem., 16, 627, 10.2174/092986709787458470 Margolis, 2007, Molecular imaging techniques in body imaging, Radiology, 245, 333, 10.1148/radiol.2452061117 Hamamura, 2010, Initial Investigation of preclinical integrated SPECT and MR imaging, Technol. Cancer Res. Treat., 9, 21, 10.1177/153303461000900103 Thayer, 2010, Dual-contrast dynamic MRI-DOT for small animal imaging, Technol. Cancer Res. Treat., 9, 61, 10.1177/153303461000900107 Barber, 2010, Combined fluorescence and X-ray tomography for quantitative in vivo detection of fluorophore, Technol. Cancer Res. Treat., 9, 45, 10.1177/153303461000900105 Davis, 2010, MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors, Acad. Radiol., 17, 271, 10.1016/j.acra.2009.11.001 Jemal, 2009, Cancer statistics, 2009, CA. Cancer J. Clin., 59, 225, 10.3322/caac.20006 Heckl, 2004, Molecular imaging: Bridging the gap between neuroradiology and neurohistology, Histol. Histopathol., 19, 651 Higuchi, 2007, Imaging of angiogenesis in cardiology, Eur. J. Nucl. Med. Mol. Imaging., 34, S9, 10.1007/s00259-007-0436-z Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Tennant, 2009, Metabolic transformation in cancer, Carcinogenesis, 30, 1269, 10.1093/carcin/bgp070 Trosko, 2004, Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication, Ann. N. Y. Acad. Sci., 1028, 192, 10.1196/annals.1322.023 Desar, 2009, Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy, Cancer Treat. Rev., 35, 309, 10.1016/j.ctrv.2008.12.001 Jadvar, 2009, 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization, J. Nucl. Med., 50, 1820, 10.2967/jnumed.108.054098 Kinahan, 2006, Dual energy CT attenuation correction methods for quantitative assessment of response to cancer therapy with PET/CT imaging, Technol. Cancer Res. Treat., 5, 319, 10.1177/153303460600500403 Shields, 1998, Imaging proliferation in vivo with [F-18]FLT and positron emission tomography, Nat. Med., 4, 1334, 10.1038/3337 Belt, 1993, Nucleoside transport in normal and neoplastic cells, Adv. Enzyme Regul., 33, 235, 10.1016/0065-2571(93)90021-5 Kong, 1992, Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3’-fluoro-3’-deoxythymidine and 3’-azido-3’-deoxythymidine, Antimicrob. Agents Chemother., 36, 808, 10.1128/AAC.36.4.808 Reske, 2006, Is 3’-deoxy-3’-(18)F-fluorothymidine a better marker for tumour response than (18)F-fluorodeoxyglucose?, Eur. J. Nucl. Med. Mol. Imaging, 33, 38, 10.1007/s00259-006-0134-2 Blankenberg, 1998, In vivo detection and imaging of phosphatidylserine expression during programmed cell death, Proc. Natl. Acad. Sci. U. S. A., 95, 6349, 10.1073/pnas.95.11.6349 Schellenberger, 2002, Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI, Acad. Radiol., 9, S310, 10.1016/S1076-6332(03)80212-X Guo, 2002, Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging, J. Magn. Reson. Imaging, 16, 172, 10.1002/jmri.10140 Folkman, 1971, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med., 285, 1182, 10.1056/NEJM197111182852108 Choyke, 2003, Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging, J. Magn. Reson. Imaging, 17, 509, 10.1002/jmri.10304 Murukesh, 2010, Biomarkers of angiogenesis and their role in the development of VEGF inhibitors, Br. J. Cancer, 102, 8, 10.1038/sj.bjc.6605483 Turkbey, 2009, Imaging of tumor angiogenesis: functional or targeted?, AJR Am. J. Roentgenol., 193, 304, 10.2214/AJR.09.2869 Tofts, 1999, Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols, J. Magn. Reson. Imaging, 10, 223, 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S Hentschel, 2007, Analysis of blood flow and glucose metabolism in mammary carcinomas and normal breast: a H2(15)O PET and 18F-FDG PET study, Nucl. Med. Commun., 28, 789, 10.1097/MNM.0b013e3282e2a880 Longo, 2008, Anti-VEGF therapy: the search for clinical biomarkers, Expert Rev. Mol. Diagn., 8, 301, 10.1586/14737159.8.3.301 Kowanetz, 2006, Vascular endothelial growth factor signaling pathways: therapeutic perspective, Clin. Cancer Res., 12, 5018, 10.1158/1078-0432.CCR-06-1520 Beer, 2006, Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man, Clin. Cancer Res., 12, 3942, 10.1158/1078-0432.CCR-06-0266 Zheng, 2004, Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4’-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4’-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbut anamide, Nucl. Med. Biol., 31, 77, 10.1016/S0969-8051(03)00111-2 Haubner, 2001, Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography, Cancer Res., 61, 1781 Schmieder, 2005, Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles, Magn. Reson. Med., 53, 621, 10.1002/mrm.20391 Bedrosian, 1999, 99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma, J. Nucl. Med., 40, 1143 Harisinghani, 2003, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer, N. Engl. J. Med., 348, 2491, 10.1056/NEJMoa022749 Jacobson, 2009, 64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4, Bioorg. Med. Chem., 17, 1486, 10.1016/j.bmc.2009.01.014 Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 Ganapathy, 2009, Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond, Pharmacol. Ther., 121, 29, 10.1016/j.pharmthera.2008.09.005 Ishiwata, 1993, A comparative study on protein incorporation of L-[methyl-3H]methionine. L-[1-14C]leucine and L-2-[18F]fluorotyrosine in tumor bearing mice, Nucl. Med. Biol., 20, 895, 10.1016/0969-8051(93)90089-D Jacobs, 2005, 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors, J. Nucl. Med., 46, 1948 Vaupel, 2005, Hypoxia in breast cancer: role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion, Adv. Exp. Med. Biol., 566, 333, 10.1007/0-387-26206-7_44 Rajendran, 2005, Imaging hypoxia and angiogenesis in tumors, Radiol. Clin. North Am., 43, 169, 10.1016/j.rcl.2004.08.004 Padhani, 2005, Where are we with imaging oxygenation in human tumours?, Cancer Imaging, 5, 128, 10.1102/1470-7330.2005.0103 Kurhanewicz, 2000, Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer, Neoplasia, 2, 166, 10.1038/sj.neo.7900081 Klonisch, 2008, Cancer stem cell markers in common cancers - therapeutic implications, Trends Mol. Med., 14, 450, 10.1016/j.molmed.2008.08.003 Hung, 2005, Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging, Clin. Cancer Res., 11, 7749, 10.1158/1078-0432.CCR-05-0876 Spitz, 2010, The evolving discipline of molecular epidemiology of cancer, Carcinogenesis, 31, 127, 10.1093/carcin/bgp246 Cherry, 2004, In vivo molecular and genomic imaging: new challenges for imaging physics, Phys. Med. Biol., 49, R13, 10.1088/0031-9155/49/3/R01 Wehrl, 2009, Pre-clinical PET/MR: technological advances and new perspectives in biomedical research, Eur. J. Nucl. Med. Mol. Imaging, 36, S56, 10.1007/s00259-009-1078-0 Cho, 2008, A fusion PET-MRI system with a high-resolution research tomograph-PET and ultra-high field 7.0 T-MRI for the molecular-genetic imaging of the brain, Proteomics, 8, 1302, 10.1002/pmic.200700744 Hofmann, 2008, MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration, J. Nucl. Med., 49, 1875, 10.2967/jnumed.107.049353 Martinez-Moller, 2009, Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data, J. Nucl. Med., 50, 520, 10.2967/jnumed.108.054726 Judenhofer, 2008, Simultaneous PET-MRI: a new approach for functional and morphological imaging, Nat. Med., 14, 459, 10.1038/nm1700 Shao, 1997, Simultaneous PET and MR imaging, Phys. Med. Biol., 42, 1965, 10.1088/0031-9155/42/10/010